About
Phoenix DX (previously LIG Biowise) is an innovative medical diagnostics company developing an ultra-rapid, point-of-care (POC) diagnostic device for infectious diseases. Its platform technology combines nucleic acid extraction, amplification, and detection into a single step, resulting in faster diagnostic turn around, lower costs and higher precision. Initially targeting diagnostics for upper respiratory tract infections (URTIs), Phoenix DX is set to transform antibiotic prescribing practices and tackle antimicrobial resistance from its base in Manchester, UK.
Technologies
Outlook
Phoenix
AI
Remote
Keywords
pointofcare diagnostics
infectious disease diagnostics
antimicrobial resistance
molecular biology
medical equipment manufacturing
medical devices
hospital & health care
Company Information
-
Employees 0
-
Founded 2014
Location
Salford, England, United Kingdom, M50 3SP
